搜索
Search
img

News Center

新闻中心

Suzhou Kintor Won "Extraordinary Biopharmaceutical Enterprise Award" of China Financing in 2019

  • Time of issue:2019-06-21

(Summary description)[June 21, 2019, Hong Kong, China] The awarding ceremony of the "2019 China Financing Awards" sponsored by "China Financing", a high-end financial magazine on Hong Kong capital market, was successfully held in Hong Kong. Suzhou Kintor Pharmaceuticals, Inc. ("Suzhou Kintor"), together with nine pharmaceutical enterprises such as WuXi Biologics, Henlius, CanSinoBio, Innovent Biologics and Hua Medicine, won "Extraordinary Biopharmaceutical Enterprise Award" of China Financing in 2019. Dr. Youzhi Tong, Chairman and Chief Executive Officer of Suzhou Kintor , was invited to attend the ceremony and accept the award on behalf of the company.

Suzhou Kintor Won "Extraordinary Biopharmaceutical Enterprise Award" of China Financing in 2019

(Summary description)[June 21, 2019, Hong Kong, China] The awarding ceremony of the "2019 China Financing Awards" sponsored by "China Financing", a high-end financial magazine on Hong Kong capital market, was successfully held in Hong Kong. Suzhou Kintor Pharmaceuticals, Inc. ("Suzhou Kintor"), together with nine pharmaceutical enterprises such as WuXi Biologics, Henlius, CanSinoBio, Innovent Biologics and Hua Medicine, won "Extraordinary Biopharmaceutical Enterprise Award" of China Financing in 2019. Dr. Youzhi Tong, Chairman and Chief Executive Officer of Suzhou Kintor , was invited to attend the ceremony and accept the award on behalf of the company.

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2019-06-21 15:23
  • Views:
Information
[June 21, 2019, Hong Kong, China] The awarding ceremony of the "2019 China Financing Awards" sponsored by "China Financing", a high-end financial magazine on Hong Kong capital market, was successfully held in Hong Kong. Suzhou Kintor Pharmaceuticals, Inc. ("Suzhou Kintor"), together with nine pharmaceutical enterprises such as WuXi Biologics, Henlius, CanSinoBio, Innovent Biologics and Hua Medicine, won "Extraordinary Biopharmaceutical Enterprise Award" of China Financing in 2019. Dr. Youzhi Tong, Chairman and Chief Executive Officer of Suzhou Kintor , was invited to attend the ceremony and accept the award on behalf of the company.
5
  Suzhou Kintor Won "2019 China Financing Award"
"China Financing Award" was sponsored by Hong Kong Finance Magazine "China Financing", organized by Wonderful Sky Financial Group, and in collaboration with authoritative organizations including Listed Companies Councilof Hong Kong Chinese Enterprises Association, Hong Kong branch of China Merger & Acquisition Association, Chinese Financial Association of Hong Kong, Chinese Securities Association of Hong Kong, Chinese Asset Management Association of Hong Kong, Hong Kong Institute of Financial Analysts and Professional Commentators Limitedand Top 100 Hong Kong Listed Companies Research Center. Selection of the award was given on the basis ofcomprehensive considerations to the objective data indicators provided by professional financial securities institutions and the opinions of the sponsors and expert review advisory panel. Known for fairness and impartiality in the review mechanism and the authoritativeness of the review committee, "China Financing Award" has received wide attention and recognition from all circles.
Suzhou Kintor has won this honor by virtue of its meticulous spirit demonstrated in unremitting commitment to the research and development of new anti-cancer drugs, and the research progress achieved, which has greatly enhanced the brand influence and reputation of Suzhou Kintor in Hong Kong capital market and affirmedthe development achievements in the field of innovative medicine of Suzhou Kintor.

Scan the QR code to read on your phone

News Center

Company News    Media Reports

Contact Us

Find Us

这是描述信息